@article{69925dbc9f97468f99fab5039d59fb93,
title = "Kidney measures to improve risk discrimination of cardiovascular events",
author = "Hideki Ishii and Toyoaki Murohara",
note = "Funding Information: H. Ishii received lecture fees from Astellas Pharma Inc., Astrazeneca Inc., Bayer Pharmaceutical Co., Ltd., Bristol-Myers Squibb Inc., Chugai Pharmaceutical Co., Ltd., Daiichi-Sankyo Pharma Inc., and MSD K. K. T. Murohara received lecture fees from Bayer Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Pfizer Japan Inc., Sanofi-aventis K. K., and Takeda Pharmaceutical Co., Ltd.; unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K.",
year = "2019",
doi = "10.1253/circj.CJ-19-0600",
language = "English",
volume = "83",
pages = "1836--1837",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "9",
}